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Abstract 
Objective: 
Network meta-analyses have extensively been used to compare the effectiveness of 
multiple interventions for healthcare policy and decision-making. However, methods 
for evaluating the performance of multiple diagnostic tests are less established. In a 
decision-making context, we are often interested in comparing and ranking the 
performance of multiple diagnostic tests, at varying levels of test thresholds, in one 
simultaneous analysis.  
 
Study design and setting: 
Motivated by an example of cognitive impairment diagnosis following stroke, we 
synthesized data from 13 studies assessing the efficiency of two diagnostic tests: 
Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA), 
at two test thresholds: MMSE <25/30 and <27/30, and MoCA <22/30 and <26/30. 
Using Markov Chain Monte Carlo (MCMC) methods, we fitted a bivariate network 
meta-analysis model incorporating constraints on increasing test threshold, and 
accounting for the correlations between multiple test accuracy measures from the 
same study.  
 
Results: 
We developed and successfully fitted a model comparing multiple tests/threshold 
combinations while imposing threshold constraints. Using this model, we found that 
MoCA at threshold <26/30 appeared to have the best true positive rate, whilst 
MMSE at threshold <25/30 appeared to have the best true negative rate. 
 
Conclusion: 
The combined analysis of multiple tests at multiple thresholds allowed for more 
rigorous comparisons between competing diagnostics tests for decision making. 
 
Keywords: 
Network meta-analysis; meta-analysis; diagnostic test accuracy; multiple tests; 
multiple thresholds 
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1. Background 
 
Evidence-based healthcare evaluations, as endorsed by the National Institute for 
Health and Care Excellence (NICE) in the UK and similar organisations worldwide, 
have highlighted the crucial role systematic reviews, including meta-analysis where 
appropriate, have to play in the decision making process to answer clinically relevant 
questions such as whether a technology works, for whom and how it compares with 
alternatives (1).  Such evidence based evaluations are important to the decision 
making process within the area of diagnostic test performance as early diagnosis of 
disease can lead to more successful treatment than if treatment is delayed.  
 
Diagnostic test accuracy is defined by Leeflang et al (2) as the ability of a test to 
distinguish between patients with a specified target condition and those without, 
and the results are usually expressed in terms of sensitivity (i.e. the proportion of 
people with the condition correctly detected by the test) and specificity (i.e. the 
proportion of people without the condition correctly detected by the test).  The 
dependence between these outcomes (i.e. sensitivity and specificity) adds an 
additional complexity that makes evidence synthesis of diagnostic test accuracy data 
more complicated than for intervention studies. The dependence between 
outcomes can occur in one of two ways. For meta-analyses of studies evaluating a 
single pair of sensitivity and specificity, the dependence between sensitivity and 
specificity occurs across studies for differing thresholds (3). For meta-analyses of 
studies evaluating multiple tests and/or multiple thresholds, and therefore, multiple 
pairs of sensitivity and specificity, the dependence between outcomes occurs both 
within and across studies. Another additional issue includes correctly estimating the 
joint conditional performance of multiple tests when they are used in combination 
(4).  A number of methods have been proposed to meta-analyse studies reporting 
single pairs of sensitivity and specificity data including independent meta-analyses of 
sensitivity and specificity (5), meta-analysis of diagnostic odds ratios (5), summary 
receiver operating curve (sROC) regression modelling (6), hierarchical sROC model 
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(7), and bivariate meta-analysis models (7, 8). In cases where the test threshold is 
suspected or known to vary between studies, the latter 2 approaches (which have 
been shown to be equivalent (9)) are the most appropriate as they allow for this 
variability in the analysis. However, neither of these incorporates test threshold 
information explicitly into the analysis, which hampers accurate prediction of test 
performance at particular thresholds; a fact which limits the clinical applicability of 
results, at least in contexts where test threshold can be explicitly specified. Work 
extending the hierarchical sROC / bivariate approach, allowing for data from multiple 
thresholds for the same tests from the same study to be synthesised, was described 
some time ago (10) but is rarely used in practice and suffers from the same 
limitation that explicit threshold value information is not included in the analysis. 
Alternative approaches have since been described (3, 11-14) including a 
generalization of the bivariate model to include the use of multivariate random 
effects (11), and the use of Poisson-correlated gamma frailty models (12). For both 
of these approaches, the number of thresholds across all studies has to be identical, 
which is often impractical in a meta-analysis setting. Multivariate regression models 
(13) and linear mixed effects models (3) have also been proposed. These methods 
consist of a two-stage approach, however, estimation of the uncertainty from stage-
one of these analyses are ignored and may lead to unrealistic results. More recently, 
Hoyer et al (14) proposed a bivariate time-to-event model for interval censored data 
incorporating random effects. This approach overcomes the limitations described 
above, and provides a flexible framework to account for various distributions of the 
underlying diagnostic marker. However, a limitation of this model is the potential 
constraint of the proportional hazards assumptions when meta-analysing ROC curves 
from studies which report a single threshold.   
 
In comparison to interventional research, methodology for meta-analysing 
diagnostic test accuracy data has relatively recently been adopted by Cochrane. As 
such, the development of guidance, and best practice statements are ever evolving. 
However, at present, the preferred Cochrane methods are suited to meta-analysing 
diagnostic test accuracy of single tests (using the statistical methods outlined above). 
From a clinical and decision-making perspective, often interest lies in assessing the 
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performance of multiple diagnostic tests with multiple thresholds in one 
simultaneous analysis, since it addresses clinically relevant questions such as: which 
test at which threshold is most effective, or most cost-effective (15). In 
interventional research, when multiple competing healthcare interventions are of 
interest, network meta-analyses (NMA) have been used extensively to compare and 
identify the “best” intervention(s). However, methods for evaluating the 
performance of multiple diagnostic tests are less established. Network meta-
analyses of healthcare interventions are commonly used to synthesise  
data from several clinical trials in similar patient populations with the aim to 
evaluate multiple interventions that may not have been compared otherwise. This 
approach combines both direct information (obtained from head-to-head trials) and 
indirect information (obtained from trials that share a common comparator) to 
obtain relative treatment effects for all interventions whilst maintaining 
randomisation. Combining direct and indirect information 
in this way assumes an additive relationship between treatment effects. In a 
diagnostic test accuracy setting, this framework has previously been adopted to 
model the difference or relative risk in sensitivity and specificity (16), as well as the 
relative Diagnostic Odds Ratio between two tests (16-18). Throughout this paper, 
network meta-analyses are used to describe the synthesis of diagnostic test accuracy 
data from a network of diagnostic tests that have been evaluated in the same study 
and thus, the same individuals. Our approach differs to the framework commonly 
used for healthcare interventions in that our approach models the absolute 
sensitivity and specificity of each test incorporating random effects to allow for 
heterogeneity, as well as similarities between data belonging to the same study, and 
the same tests within studies (i.e. to account for multiple thresholds within tests).  
 
Through careful consideration of a motivating example, this paper sets out an 
approach to network meta-analysis of diagnostic test accuracy studies which allows 
for both the incorporation of multiple tests and multiple explicit threshold values, 
potentially reported by the same studies. Section 2 introduces the motivating 
example. Section 3 discusses the visual representation of diagnostic test accuracy 
data, highlighting where appropriate, key assumptions that are revisited throughout 
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the remainder of this article. Section 4 describes each of the proposed meta-analysis 
models. Section 5 presents the results from the analysis of the motivating example 
and Section 6 concludes this article with a discussion. 
 
2. Motivating example 
Cognitive impairment is highly prevalent in stroke survivors and it can lead to 
increased mortality, disability, and institutionalization.  Early detection of cognitive 
impairment is an essential step in the efficient management of patient care. In the 
UK, screening for cognitive impairment is recommended by governing bodies such as 
the National Institute for Health and Care Excellence (NICE) and the Royal College of 
Physicians (RCP). However, although cognitive assessment is recommended in 
various clinical guidelines, there is no consensus on how to efficiently diagnose 
patients, where differing guidelines recommend differing tests and thresholds (19). A 
robust synthesis of the evidence in one simultaneous analysis has the potential to 
provide an evidence base where currently best clinical practice is primarily opinion 
based.  
 
In a study by Lees et al (20), the authors investigated the test accuracy of multiple 
screening tests for the diagnosis of cognitive impairment and dementia in stroke 
patients. Cognitive impairment is an umbrella term that encompasses any objective 
memory and thinking problem. It includes, but is not limited to, the clinical 
syndrome of dementia. Gold standard assessment for cognitive impairment is a 
detailed examination of various aspects of cognition (neuropsychological battery 
(NPB)), while there is no consensus on the ‘gold’ standard ante-mortem diagnosis of 
dementia, dementia diagnosis is currently made according to clinical criteria which 
can often be informed by data from  NPB. In the Lees et al review, as the index tests 
of interest were ‘screening’ tests, the authors decided to include both cognitive 
impairment on NPB and clinical dementia diagnosis as their reference standard. The 
authors were able to synthesize data from 13 diagnostic test accuracy studies for 
two key screening tests; Folstein’s Mini Mental State Examination (MMSE) and 
Montreal Cognitive Assessment (MoCA). MMSE and MoCA examinations are based 
on a scoring system, where a higher value indicates a more desired response from 
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the participant. Thus a disease-positive response on a lower test threshold would 
suggest a more severe case of cognitive impairment. The authors focused on 2 
disparate cut points per test for dementia diagnosis; MMSE <25/30, MMSE <27/30, 
MoCA <22/30, MoCA <26/30. In this article, each of the test-threshold combinations 
are treated as independent tests. Figure 1 illustrates the network of comparative 
studies. The nodes represent each of the test-threshold combinations of interest. 
The dashed interconnecting lines illustrate that a comparative study examining both 
tests in the same patient population exists. Typically networks of treatment 
comparisons are presented alongside network meta-analyses of healthcare 
interventions, where the interconnecting lines represent direct evidence on the 
relative differences between treatments. Figure 1 differs to a network of treatment 
comparisons for network meta-analyses of healthcare interventions whereby the 
interconnecting lines represent a comparative study illustrating tests that have been 
undertaken in the same cohort of patients and thus, there is a within-study 
dependence between pairs of sensitivity and specificity for these tests. Table 1 
shows the extracted data from the original papers. The choice of test thresholds 
were determined by the most commonly reported test-threshold combinations in 
the published literature at the time of publication. The reference standard tests 
included NPB and clinical diagnosis of dementia (and the authors assumed that these 
were perfect, as do we in this paper). In this example, Lees et al (20) pooled data 
from studies using both reference tests. Data from 12, 5, 4, and 6 studies were 
pooled in separate bivariate meta-analyses for MMSE<25/30, MMSE<27/30, 
MoCA<26/30 and MoCA<22/30, respectively.  
 
 
 
>> insert Figure 1: Network of comparative studies<< 
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>> insert Table 1: Diagnostic test accuracy data obtained from the original papers<< 
 
 
3. Illustrating diagnostic test accuracy data 
This section highlights some of the key principles of diagnostic test accuracy data 
through the use of visual representations. Figures 2 and 3 illustrate the relationship 
between the thresholds of the same study for MMSE and MoCA, respectively. The 
nodes represent the observed sensitivity and specificity, colour-coded for each 
threshold; and the corresponding number represents the exact threshold used. The 
interconnecting lines illustrate the ROC curve for each study that reports multiple 
threshold values. One of the properties of an ROC curve is that higher test thresholds 
for a positive outcome must, mathematically, have an increased sensitivity but 
decreased specificity.  For the remainder of this article, this property will be referred 
to as a threshold assumption. In this example, MMSE and MoCA are scored out of 30 
points, with a point deducted for each error. Lower scores therefore suggest greater 
impairment. If the ‘test positive’ threshold is lowered then at the lower threshold 
the test is more specific and less sensitive, and thus should lie in the lower left hand 
side of the ROC space. From Figure 2, it is evident that there is a large amount of 
heterogeneity in sensitivities and specificities reported between the studies 
identified by Lees et al (20), where datapoints with lower thresholds for MMSE lie 
towards the top left hand side of the ROC space, above that of higher thresholds.  
Figure 4 illustrates schematically the relationship between the threshold assumption 
and that of heterogeneity. Heterogeneity between studies can be described as the 
difference in ROC curves between studies, shifting the ROC curve in a Southeast or 
Northwest direction from the summary ROC. The threshold assumption shifts the 
observed sensitivity and specificity in a Northeast or Southwest direction along the 
study specific ROC curve.  
  
Figure 2: Relationship of increasing test thresholds within MMSE 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
9 
 
>> insert fig 2
<< 
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>>insert  
 
<< 
 
 
 
>> insert Figure 4: Schematic relationship of the impact of heterogeneity in test performance due to threshold 
and between study heterogeneity. The labels "Lower threshold" and "Higher threshold" apply specifically to 
the given example.<< 
 
 
4. Models and estimation 
4.1. Network meta-analysis for diagnostic test accuracy studies  
Building on the bivariate meta-analysis model described by Reitsma et al (8)  and 
Sutton et al (15), let the observed number of true positives,	, for the ith 
observation be considered as a binomial count from a sample of disease positive 
individuals, .	This information allows for estimation of the diagnostic sensitivity, 
	, which is associated with the rate of accurate detection of diseased individuals. 
Likewise, let the number of true negatives, 	, be considered as a binomial count 
from a sample of disease negative individuals, 	 .	This information allows for 
estimation of the specificity of the test, , which is associated with the rate of 
accurate detection of non-diseased individuals, such that:  
~			,  
	~		, 	 
( 1 ) 
Logistic regression models can be used to specify sensitivity and specificity. Across 
studies, the sensitivity and specificity of each test are likely to be correlated. To 
account for this across-study dependence the (logit) sensitivity, 	,	and 
specificity, ,	of observation i, where observation i represents each pair of 
sensitivities and specificities for each study,  are drawn from a bivariate normal 
distribution with mean equal to the pooled test accuracy estimates of sensitivity, , and specificity,  ,	with between-observation covariance matrix : 
 
	 ∼   !"
# , $ 
Figure 3: Relationship of increasing test thresholds within MoCA 
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 = " &' (&&(&& &' #, 
( 2 ) 
where & and & denote the between-observation standard deviation in logit 
transformed sensitivity and specificity, and ( denotes the between-observation 
correlation. In order to model the inherent correlations between multiple sensitivity 
and specificity data-pairs from the same study, a variance component model can be 
used (21) such that diagnostic test-threshold combinations are considered fixed 
effects, while study, and study-specific diagnostic test are considered random 
effects. Study and study-specific diagnostic test are nested within each observation. 
The model is given by:  
 = )*,+ + - + .-,* 
 = /*,+ + - + 0-,* 
( 3 ) 
where ) and / denote fixed effects of sensitivity and specificity due to diagnostic 
test, j, and test-threshold, k, respectively. Parameters c and d, and e and f, denote 
random effects of sensitivity and specificity due to study, l, and the interaction 
between study, l, and diagnostic test, j, respectively. Non-informative prior 
distributions were specified for the test-specific and threshold-specific accuracy 
parameters on the logit scale (with more information given in technical appendix 
A.1). All models were estimated in a Bayesian framework using Markov Chain Monte 
Carlo (MCMC) simulation, and implemented in the WinBUGS 1.4.3 software (22).  
Example WinBUGS code is given in Appendix A.2.   
 
4.2. Network meta-analysis incorporating threshold constraints 
Building on the network meta-analysis framework of 4.1, constraints can be specified 
on the underlying threshold parameters, assuming that overall, higher test-
thresholds have an increased sensitivity but decreased specificity. We applied these 
constraints using a method described by Owen et al (23), where the authors place 
constraints on increasing doses of an intervention for comparative effectiveness 
research. In this paper, imposing constraints allows information to be borrowed 
between thresholds within a test, and thus potentially increase the precision in the 
estimated test accuracy for decision-making (which is further discussed in Section 6). 
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An alternative approach is to specify the underlying cumulative distribution function 
of the tests (3, 12, 14). This approach is flexible to multiple and different thresholds. 
However, specifying constraints on the summary estimates of the accuracy measures 
for increasing test thresholds, as described in this paper, makes fewer assumptions 
about the distributional form of these estimates and rather this approach simply 
allows the summary estimates to be greater than or equal to, or less than or equal 
to, the reference threshold. 
  
 5. Analysis of the motivating example 
In this section, we synthesized diagnostic test accuracy data across all tests and 
thresholds of interest. This includes MMSE at threshold <25 and <27, and MoCA at 
threshold <22 and <26. We illustrate estimates of diagnostic test accuracy using a 
number of models each with different heterogeneity and correlation assumptions, as 
described in the technical appendix (Appendix A.1). We extend each of these models 
to incorporate constraints on increasing thresholds.  
Table 2 gives the model fit statistics for each of these models. Using measures of DIC, 
it is apparent that there is very little difference in model fit across all models 
considered (a difference in DIC > 5 is considered an important difference). For this 
reason, the most simplistic model, assuming a common heterogeneity and 
correlation parameter across models was used for illustration. The results from the 
remaining models are given in Appendix A.3.  
 
>> insert Table 2: Model fit statistics<< 
 
 
5.1. Assuming common heterogeneity and correlation parameters across tests 
This section illustrates the results from a model assuming a common heterogeneity 
and correlation parameter across multiple, diverse tests. Section 5.1.1 presents 
estimates of test accuracy from a model without threshold constraints and section 
5.1.2 presents results from a model with threshold constraints. 
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5.1.1. Model without threshold constraints 
Table 3 displays the results of the summary test accuracy measures, relative rankings 
and probabilities that each test was the most accurate overall in terms of the true 
positive rate (sensitivity) and true negative rate (specificity). Combining diagnostic 
test accuracy data for all test-threshold combinations illustrated that MoCA<26 
appeared to have the optimal true positive rate (sensitivity: 0.97, 95%CrI: 0.94, 0.99) 
for 99% of MCMC iterations. There appeared to be little difference between 
MMSE<27 and MoCA<22 in terms of sensitivity, with each of these tests ranking in 
second (95%CrI: 2,3) and third place (95%CrI: 2,4), respectively. However, MoCA<22 
appeared to have a better true negative rate (specificity: 0.77, 95%CrI: 0.67, 0.85) 
compared to MMSE<27 (specificity: 0.58, 95%CrI: 0.45, 0.70), and subsequently 
ranked in second place for specificity (Rank: 2, 95%CrI: 1,2). MMSE<25 appeared to 
have the optimal true negative rate overall (specificity: 0.84, 95%CrI: 0.79, 0.89), 
ranking in first place for 97% of model iterations.  
   
5.1.2. Model with threshold constraints 
Incorporating threshold constraints on increasing thresholds marginally reduced the 
between-observation standard deviation for specificity (Table 2). However, including 
threshold constraints had very little impact on the posterior point estimates which 
mirror those of the unconstrained model (Table 3). Overall, incorporating threshold 
constraints appeared to marginally increase precision in the effect estimates. 
Subsequently, MoCA<26 ranked in first place for sensitivity for 100% of MCMC 
iterations. Incorporating threshold constraints reduced the variability within-studies. 
The estimated within-study standard deviation for sensitivity was 0.62 (SD: 0.31) 
compared to 0.63 (SD: 0.30) from the unconstrained model. Similarly, the estimated 
within-study standard deviation for specificity was 0.42 (SD: 0.21) compared to 0.44 
(SD: 0.20) from the unconstrained model. However, the variability within-tests 
within a study marginally increased when incorporating threshold constraints. For 
sensitivity, the estimated standard deviation from the model incorporating threshold 
constraints was 0.30 (SD: 0.22) compared to 0.28 (SD: 0.22) from the unconstrained 
model. For specificity, the estimated standard deviation was 0.27 (SD: 0.20) 
compared to a standard deviation of 0.25 (SD: 0.17) for the unconstrained model. 
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Figure 5 displays the posterior point estimates and 95% credible regions in ROC 
space. Whilst MoCA<26 and MMSE<25 rank in first place for sensitivity and 
specificity, respectively, joint and equal consideration of these diagnostic measures 
would suggest that MoCA<22 appears to have the optimal diagnostic accuracy 
overall. Table 4 gives the estimated mean difference in sensitivity (top right) and 
specificity (bottom left) between each of the tests. In comparison to MoCA<22, the 
estimated sensitivity gained by receiving the optimal true positive test (MoCA<26) is 
0.14 with corresponding 95% credible interval (0.07,0.25). Similarly, the estimated 
specificity gained from receiving the optimal true negative test (MMSE<25) is 0.07 
with corresponding 95% credible interval (-0.01,0.18). As these intervals are close to, 
or span, the point of no difference, there is no strong evidence to suggest that 
MoCA<22 loses efficiency in accurate diagnosis. 
 
>>insert Table 3: Posterior point estimates and 95% credible intervals obtained from a network meta-analysis 
model assuming a common between-observation standard deviation and correlation parameter<< 
 
 
 
>> insert Figure 5: Posterior point estimates and 95% credible regions in ROC space obtained from a model 
incorporating threshold constraints and assuming a common heterogeneity and correlation parameter across 
tests<< 
 
 
>> insert Table 4: Estimated mean difference (95%CrI) in sensitivity (top right) and specificity (bottom left) 
between each test-threshold combination (row – column) obtained from a model incorporating threshold 
constraints and assuming a common heterogeneity and correlation parameter across tests << 
Above the leading diagonal gives estimates of the mean difference (row – column) in sensitivity (95%CrI), and 
below the leading diagonal gives estimates of the mean difference in specificity (95%CrI) 
 
 
6. Discussion 
In this paper, we propose a unified network meta-analysis framework for 
synthesizing diagnostic test accuracy data which allows for both the incorporation of 
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multiple tests and multiple explicit thresholds of the same tests. We further 
developed this framework to incorporate constraints on increasing test thresholds 
such that estimates for higher test thresholds had an increased sensitivity but 
decreased specificity compared to lower thresholds of the same test. In this way, by 
departing from the usually conducted separate analyses of different tests, the 
combined analysis of multiple tests/threshold allows for more detailed and rigorous 
comparisons between competing tests.  For example in the dementia example 
presented, we found that MoCA<26 had the optimum true positive rate, and 
MMSE<25 had the optimum true negative rate of diagnosing cognitive impairment 
following a stroke. While joint and equal consideration of sensitivity and specificity 
suggested that MoCA<22 appeared to have the optimal diagnostic test accuracy 
overall.  
 
From a decision makers’, clinicians’, and patients’ perspective, interest lies in both 
the true positive rate (sensitivity) and true negative rate (specificity) of a diagnostic 
test in order to efficiently manage patient care. Therefore, unlike the analysis 
considered here, consideration to the relative weighting of sensitivity and specificity 
will be required (i.e. the relative health implications of a false negative compared to 
a false positive result). In order to make robust decisions regarding the optimal 
diagnostic test in terms of clinical-effectiveness and/or cost-effectiveness, a fully 
comprehensive clinical or economic decision model will need to be developed 
incorporating potential treatment plans and longer-term follow-up.  
  
Further extensions to the network meta-analysis framework described in this paper 
could include incorporating meta-regression methods. Both observation or study-
level covariates could easily be included in the bivariate component of the model as 
described by Reitsma et al (8), with the aim to explain some of the heterogeneity 
between observations or between studies. Further work could also look to derive a 
set of inconsistency equations to assess consistency between different sources of 
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information i.e. comparative versus non-comparative studies.  
 
In clinical practice, a sequential approach to testing is often used. Thus stroke 
patients may receive a brief diagnostic test initially, and those identified as 
remaining ‘at risk’ may receive further, more comprehensive, testing such as NPB or 
clinical diagnosis. In this example, it may be reasonable to administer MoCA<26 
initially to ensure that the optimal number of true negative patients are identified 
and discharged from further routine cognitive assessment.  Alternatively, MoCA<22 
may be used initially to ensure that the maximum number of true positive and true 
negative patients are identified. The utility of a staged and triaged approach to 
diagnostic testing in this setting remains unanswered and provides an opportunity 
for further work, as does the further development of statistical methods to evaluate 
the performance of sequences of tests taking lack of dependence into account (4, 
24).  
 
A potential limitation of our approach is that it treats different test and threshold 
combinations as separate tests for the purposes of the analysis, and thus full sROC 
plots are not estimated across different thresholds, as has been done elsewhere (3, 
10-14), however methods to estimate full sROC curves have not taken into account 
explicit threshold values until very recently (14, 25), or allow for constraints to be 
placed on the heterogeneity which can be attributed to threshold differences. 
Combining a comparative framework such as the model described in this paper, with 
the flexible approach of modelling the distributional form of multiple test thresholds 
such as the model described by Hoyer et al (14, 25), whereby both the model 
parameters and distributional forms could be estimated simultaneously, is an 
opportunity for further work.  
 
Further, if studies do not report the threshold values used, or the thresholds cannot 
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be explicitly expressed, as is often the case for tests involving the interpretation of 
some sort of diagnostic image etc, then the performance of a test at different 
thresholds cannot be estimated via the model presented. However this is not an 
argument for not using the valuable extra information when thresholds are known, 
and more generally there is no reason why the same methodology should be used in 
these two different contexts (despite this being the case historically). 
 
Table 5 describes the similarities and differences between a number of additional 
approaches in the current literature to synthesise diagnostic test accuracy data from 
multiple tests (16, 26-31). All of these methods extend the bivariate model of 
Reitsma et al (8) to synthesise data for two or more tests. Trikalinos et al (26), Hoyer 
and Kuss (27), and Cheng (31) make use of multinomial distributions to model the 
within-study variation for multiple tests, whilst Dimou et al (30) makes use of 
multivariate normal distributions on logit sensitivities and specificities to account for 
within-study covariances. If full cross-tabulations, i.e. the full response array across 
all competing tests, are available, then the correlation between tests can be taken in 
to account as in Trikalinos et al (26), Dimou et al (30), and Cheng (31). These 
approaches have the advantage of appropriately modelling the within-study 
covariance structure, however, partial or full cross-tabulations are required for a 
sufficient number of studies in order to adequately model the correlation between 
tests (31). A limitation of these approaches is that as the number of competing tests 
increases, the number of parameters to be estimated by the model rapidly increases, 
which can result in issues with model convergence (31). Cheng (31) further considers 
a multivariate extension of the HSROC model by Rutter and Gatsonis (7), and 
explores the use of beta-binomial marginals and multivariate Gaussian copulas. The 
author found that use of the beta-binomial marginal and multivariate Gaussian 
copulas produced less biased estimates of the posterior mean summary points 
compared to the multivariate extension of the bivariate model and HSROC model, 
however this approach appeared to be computationally expensive. Nyaga et al (28, 
29) use a two stage hierarchical model based on the logit transformed sensitivity and 
specificity (28), and a one-stage approach based on the beta-binomial distribution 
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modelling on the probability scale (29). Both models include shared random effects 
to induce study level correlations. This approach is most similar to the model we 
describe in this paper. However, our model further incorporates shared random 
effects on test to account for multiple thresholds and applies constraints on 
increasing test-thresholds. Similarly to the model outlined in this paper, many of the 
approaches described in Table 5 adopt an arm-based approach and model the 
absolute measures of test accuracy (26-31). Menten and Lesaffre (16) developed a 
contrast-based approach, which models both the direct (or head-to-head) 
comparisons of diagnostic tests as well as indirect comparisons through a common 
diagnostic test. This approach directly models the relative logit sensitivities and 
specificities between multiple tests. This model can be further extended to a 
hierarchical latent class model to account for imperfect gold standards. A contrast-
based approach works well if all studies evaluate all diagnostic tests. In the case of 
mixed reporting, further assumptions regarding the missingness of data is required. 
In a comparison between the contrast-based approach of Menten and Lesaffre (16) 
and a hierarchical arm-based approach of Nyaga et al (28), Nyaga et al (28) argue 
that an arm-based approach may be more appealing than contrast-based 
approaches since it allows for a more straightforward interpretation of the 
parameters, makes use of all available data resulting in increased precision, and 
adopts a more natural variance-covariance structure. In choosing an approach to 
synthesise diagnostic test accuracy data for multiple tests, the user needs to 
consider a number of factors related to the decision question. The first of which is 
the available data; if partial, or full cross-tabulations are available for a sufficient 
number of studies, a multivariate approach may be preferred to adequately model 
the within-study correlation structures (16, 26, 30, 31). If there are a number of test-
thresholds of interest, a multivariate approach to the HSROC model (31), or an 
extension to the multinomial approach as described by Hoyer and Kuss (27) may be 
most appropriate.  However, if there are many competing diagnostic tests, the 
number of additional parameters to be estimated by a multivariate model may be 
too large causing issues with model convergence. In this instance, a hierarchical 
model  (28, 29), including the model described in this paper, may be preferred. 
Furthermore, in the case of many competing tests and multiple test thresholds, our 
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approach using shared random effects and constraints on increasing test thresholds 
may be considered. Indeed, a comprehensive comparison of all of the approaches 
described in Table 5, including an assessment of model performance under different 
criteria and different reporting structures, is still required and would be a valuable 
addition to the current literature.  
 
In this paper, we evaluated a number of models each with different assumptions 
regarding the heterogeneity parameters and correlation parameters. The first model 
assumed common heterogeneity and correlation parameters across tests, the 
second model assumed common heterogeneity and test-specific correlation 
parameters, and the third model assumed test-specific heterogeneity parameters 
and a common correlation parameter. It is worth noting that allowing both 
heterogeneity and correlation parameters to be test-specific leads to 
unidentifiability of the covariance matrix, and thus causes issues with model 
convergence.  
 
In conclusion, this paper proposes a number of network meta-analysis models for 
synthesizing diagnostic test accuracy data. The proposed frameworks allow for the 
analysis of multiple tests at multiple thresholds together with the option to 
incorporate constraints on increasing test thresholds. It could be argued that 
constraints on threshold effects should be applied to all models with explicit 
threshold information regardless of model fit, due to the implicit threshold 
assumption which by definition must be satisfied (but is not imposed by previous 
models commonly fitted). Incorporating this information through the use of 
constraints has the potential to more appropriately attribute variability between 
results to (genuine) threshold effects and better explain heterogeneity between 
studies.   
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>> insert Table 5: Approaches to synthesising diagnostic test accuracy data of multiple tests<< 
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Table 1: Diagnostic test accuracy data obtained from the original papers 
Study Author Test TP FP FN TN Sensitivity (95%CI) Specificity (95%CI) 
Blake 2002 MMSE<25 19 10 12 71 0.61 [0.42,0.78] 0.88[0.78,0.94] 
Bour 2010 MMSE<25 21 29 1 143 0.95 [0.77,1.00] 0.83 [0.77,0.88] 
Cumming 2010 MMSE<25 48 22 10 69 0.83 [0.71,0.91] 0.76 [0.66,0.84] 
Cumming 2013 MMSE<25 21 4 17 17 0.55 [0.38,0.71] 0.81 [0.58,0.95] 
 MMSE<27 35 10 3 11 0.92 [0.79,0.98] 0.52 [0.30,0.74] 
 MoCA<26 39 12 0 9 1.00 [0.91,1.00] 0.43 [0.22,0.66] 
 MoCA<22 30 5 9 16 0.77 [0.61,0.89] 0.76 [0.53,0.92] 
de Koning 1998 MMSE<25 44 51 11 178 0.80 [0.67,0.90] 0.78 [0.72,0.83] 
Dong 2010 MMSE<25 52 10 8 45 0.87 [0.75,0.94] 0.82 [0.69,0.91] 
 MMSE<27 45 17 3 26 0.94 [0.83,0.99] 0.60 [0.44,0.75] 
 MoCA<22 54 13 6 42 0.90 [0.79,0.96] 0.76 [0.63,0.87] 
Dong 2012 MMSE<25 28 32 4 65 0.88 [0.71,0.96] 0.67 [0.57,0.76] 
 MoCA<22 53 65 7 114 0.88 [0.77,0.95] 0.64 [0.56,0.71] 
Godefroy 2011 MMSE<25 45 2 19 29 0.70 [0.58,0.81] 0.94 [0.79,0.99] 
 MMSE<27 55 12 9 19 0.86 [0.75,0.93] 0.61 [0.42,0.78] 
 MoCA<26 60 20 4 11 0.94 [0.85,0.98] 0.35 [0.19,0.55] 
 MoCA<22 48 4 16 28 0.75 [0.63,0.85] 0.88 [0.71,0.96] 
Grace 1995 MMSE<25 20 9 26 46 0.43 [0.29,0.59] 0.84 [0.71,0.92] 
Morris 2012 MMSE<25 21 3 15 10 0.58 [0.41,0.74] 0.77 [0.46,0.95] 
 MMSE<27 30 8 6 5 0.83 [0.67,0.94] 0.38 [0.14,0.68] 
Pendlebury 2012 MMSE<25 11 3 8 69 0.58 [0.33,0.80] 0.96 [0.88,0.99] 
 MMSE<27 15 15 4 57 0.79 [0.54,0.94] 0.79 [0.68,0.88] 
 MoCA<26 19 39 0 33 1.00 [0.82,1.00] 0.46 [0.34,0.58] 
 MoCA<22 13 11 6 61 0.68 [0.43,0.87] 0.85 [0.74,0.92] 
Salvadori 2013 MoCA<26 78 46 2 29 0.97 [0.91,1.00] 0.39 [0.28,0.51] 
 MoCA<22 73 18 7 58 0.91 [0.83,0.96] 0.76 [0.65,0.85] 
Srikanth 2006 MMSE<25 4 4 4 67 0.50 [0.16,0.84] 0.94 [0.86,0.98] 
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Table 2: Model fit statistics 
Model Posterior between-
observation SD(s) 
  Correlation 
parameter(s) 
  DIC 
 Sensitivity Specificity      
 MMSE  MoCA MMSE MoCA MMSE MoCA    
Assuming common heterogeneity and correlation parameters across tests 
       
Without 
threshold 
constraints 
0.28 (SD:0.21) 0.17 (SD:0.13) -0.17 (SD:0.70)   281.59 
With 
threshold 
constraints 
0.29 (SD:0.21) 0.16 (SD:0.13) -0.16 (SD:0.70)   281.23 
Assuming common heterogeneity and test-specific correlation parameters 
 
Without 
threshold 
constraints 
0.29 (SD:0.22) 0.17 (SD:0.13) -0.14 
(SD:0.71) 
-0.01 
(SD:0.71) 
  281.64 
With 
threshold 
constraints 
0.29 (SD:0.21) 0.17 (SD:0.13) -0.20  
(SD:0.70) 
0.02 
(SD:0.71) 
  281.18 
Assuming test-specific heterogeneity and common correlation parameters across tests 
 
Without 
threshold 
constraints 
0.39 
(SD:0.27) 
0.29 
(SD:0.21) 
0.45 
(SD:0.38) 
0.22 
(SD:0.19) 
-0.28 (SD:0.68)   282.94 
With 
threshold 
constraints 
0.40 
(SD:0.27) 
0.28 
(SD:0.20) 
0.44 
(SD:0.38) 
0.21 
(SD:0.19) 
-0.28  (SD:0.68) 
 
  282.82 
 
Table 3: Posterior point estimates and 95% credible intervals obtained from a network meta-analysis model 
assuming a common between-observation standard deviation and correlation parameter 
Test Sensitivity 
(95%CrI) 
Specificity 
(95%CrI) 
Rank best 
sensitivity 
(95%CrI) 
p(Best) 
sensitivity 
Rank best 
specificity 
(95%CrI) 
p(Best) 
specificity 
Without threshold constraints 
MMSE<25 0.72 
(0.61, 0.82) 
0.84  
(0.79, 0.89) 
4 (3,4) 0 1 (1,2) 0.97 
MMSE<27 0.89 
(0.81, 0.95) 
0.58  
(0.45, 0.70) 
2 (2,3) 0.01 3 (3,3) 0 
MoCA <22 
 
0.82 
(0.70, 0.91) 
0.77 
(0.67, 0.85) 
3 (2,4) 0 2 (1,2) 0.03 
MoCA <26 
 
0.97 
(0.94, 0.99) 
0.35  
(0.23, 0.48) 
1 (1,1) 0.99 4 (4,4) 0 
With threshold constraints 
MMSE<25 0.73 
(0.62, 0.82) 
0.84  
(0.79, 0.88) 
4 (3,4) 0 1 (1,2) 0.96 
MMSE<27 0.90 
(0.81, 0.95) 
0.58  
(0.44, 0.70) 
2 (2,3) 0 3 (3,3) 0 
MoCA <22 
 
0.83 
(0.71, 0.91) 
0.77 
(0.67, 0.86) 
3 (2,4) 0 2 (1,2) 0.04 
MoCA <26 
 
0.98 
(0.94, 0.99) 
0.35 
(0.22, 0.47) 
1 (1,1) 1 4 (4,4) 0 
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Table 4: Estimated mean difference (95%CrI) in sensitivity (top right) and specificity (bottom left) between 
each test-threshold combination (row – column) obtained from a model incorporating threshold constraints 
and assuming a common heterogeneity and correlation parameter across tests 
  
MMSE<25 MMSE<27 MoCA<22 MoCA<26 
MMSE<25 - 0.17 (0.08,0.26) 0.10 (-0.01,0.22) 0.25 (0.15,0.35) 
MMSE<27 0.26 (0.15,0.39) - -0.07 (-0.18,0.03) 0.08 (0.02,0.16) 
MoCA<22 0.07 (-0.01,0.18) -0.19 (-0.33,-0.06) - 0.14 (0.07,0.25) 
MoCA<26 0.49 (0.38,0.61) 0.23 (0.08,0.37) 0.42 (0.31,0.52) - 
Above the leading diagonal gives estimates of the mean difference (row – column) in sensitivity (95%CrI), and 
below the leading diagonal gives estimates of the mean difference in specificity (95%CrI) 
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Table 5: Approaches to synthesising diagnostic test accuracy data of multiple tests 
Reference  Model Description Type of 
model 
Available data Number of 
tests 
Multiple 
thresholds 
per test 
Imperfect 
GS 
(26) Trikalinos, T. A., 
(2014). Research 
Synthesis Methods. 
 
Multinomial model approximated by 
multivariate normal distribution, modelling 
the joint TPR and FPR. Correlations 
between tests are modelled as random 
parameters. 
 
 
Arm-
based  
Full cross-
tabulations 
2 index tests + 
GS  
No No 
(16) Menten, J. and 
Lesaffre, E. (2015). 
BMC Medical 
Research 
Methodology. 
Hierarchical model which is partly based on 
contrasts between transformed sensitivity 
and specificity (similar to that of NMA for 
interventions) 
 
Adds in allowance for imperfect GS by 
modelling response pattern across tests as 
multinomial: latent class models  
 
Contrast-
based 
Full cross-
tabulations 
3 index tests + 
multiple GS 
 
No Yes 
(27) Hoyer, A. and Kuss, 
O. (2016). 
Statistical Methods 
in Medical 
Research. 
 
Multinomial model similar to that of 
Trikalinos et al (21) but does not 
account for correlations between tests 
since full cross-tabulations are not used. 
This model can be extended to account for 
multiple test thresholds.  
 
Arm-
based 
2x2 tables for each 
test versus GS only 
2 index tests + 
GS from each 
study 
Yes  No 
(28, 
29) 
Nyaga, V. N., et al. 
(2016a,b). 
Two-stage hierarchical model based on 
logit transformed sensitivity and specificity. 
Arm-
based 
2 x 2 tables for each 
test versus GS only  
11 tests (in 
example 
No No 
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Statistical Methods 
in Medical 
Research. 
Shared random effects are specified to 
induce study level correlations. 
 
One stage approach modelling directly on 
the probability scale (using beta-binomial 
distribution) without logit transformation. 
dataset) 
Between 1 
and 6 tests 
per study. 
(30) Dimou, N. L, et al. 
(2016). Statistics in 
Medicine. 
 
Multivariate normal distribution with 
closed form formulae for the within-study 
covariance matrix (needs full cross-
tabulations). Full reporting then used to 
impute when only 2 x 2 table information is 
presented. Correlation between tests are 
estimated and “plugged in”. 
Arm-
based 
Full cross-tabulation 
and 2x2 tables for 
each test versus GS 
only  
2 index tests + 
GS 
(Not all 
studies have 
to report both 
tests) 
No No 
(31) Cheng, W. (2016). 
Repository Library, 
Brown University 
(Doctoral Thesis)  
Multinomial model 
with decomposition of test and study 
specific effects (Chapter 2) 
 
Multivariate extension of the HSROC model 
(Chapter 3) 
 
Beta-binomial marginals 
and multivariate 
Gaussian copulas (Chapter 4) 
 
All models account for study-type specific 
effects and within study-type 
random effects 
 
Arm-
based 
Full cross-
tabulations, 
partially crossed-
tabulations, 2x2 
tables for each test 
versus GS only 
3 index tests + 
GS 
No 
 
 
 
 
Yes 
 
 
 
 
No 
No 
GS: Gold standard 
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Figure 1: Network of comparative studies 
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Figure 3: Relationship of increasing test thresholds within MoCA 
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Figure 4: Schematic relationship of the impact of heterogeneity in test performance due to threshold and between study 
heterogeneity. The labels "Lower threshold" and "Higher threshold" apply specifically to the given example. 
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Figure 5: Posterior point estimates and 95% credible regions in ROC space obtained from a model incorporating threshold 
constraints and assuming a common heterogeneity and correlation parameter across tests 
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What’s new? 
• Methods for meta-analysing diagnostic test accuracy data are suited to the analysis of single 
tests. 
• We propose a unified model for synthesising diagnostic test accuracy data of multiple tests 
at multiple explicit thresholds. 
• Building on this model, we incorporate constraints on increasing test thresholds such that 
higher test thresholds have an increased sensitivity but decreased specificity. 
• Incorporating constraints on threshold effects has the potential to more appropriately 
attribute variability between results to genuine threshold effects and better explain 
heterogeneity between studies. 
• A network meta-analysis framework allows comparisons to be made between all competing 
diagnostic tests and consequently inferences regarding the relative ranking of each test can 
be made for healthcare decision making. 
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